Kinnosuke Matsumoto Selected Research

Pneumonia (Pneumonitis)

3/2022	Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination.
1/2022	DOCK2 is involved in the host genetics and biology of severe COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kinnosuke Matsumoto Research Topics

Disease

11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2020
4	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2022 - 01/2020
4	COVID-19 03/2022 - 01/2022
3	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2021
2	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2022
2	Pneumonia (Pneumonitis) 03/2022 - 01/2022
2	Neoplasms (Cancer) 01/2022 - 03/2021
2	Infections 01/2022 - 01/2022
1	Abscess 01/2023
1	Disease Progression 03/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Thymoma (Thymic Carcinoma) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Coinfection 01/2022
1	Hemoptysis 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Cytomegalovirus Infections (Inclusion Disease) 01/2022
1	Sepsis (Septicemia) 01/2022

Drug/Important Bio-Agent (IBA)

5	Docetaxel (Taxotere)FDA Link 04/2023 - 04/2021
5	RamucirumabIBA 04/2023 - 04/2021
4	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2020
3	NivolumabIBA 01/2024 - 03/2021
2	PlatinumIBA 01/2024 - 01/2022
1	IpilimumabIBA 01/2024
1	pembrolizumabIBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	mRNA VaccinesIBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	VaccinesIBA 03/2022
1	COVID-19 VaccinesIBA 03/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2022
1	lenvatinibIBA 01/2022
1	cilnidipineIBA 01/2022
1	azilsartanIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	SteroidsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Interferon Type IIBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 03/2021

Therapy/Procedure

5	Therapeutics 04/2023 - 04/2021
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2022
1	Immunotherapy 01/2022